| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer
1 company
O'Kane Kieran is a Chief Commercial Officer at BDSX. Recent filings cover 0 purchases and 24 sales. Those positions are worth an estimated $191K at current prices.
Our model assigns O'Kane Kieran a middling insider score of 64/100, based on 23 past trades. Over a 12-month horizon, 57.1% of those trades were profitable, with an average 12-month return of +11.7%.
O'Kane Kieran's largest disclosed position is in BDSX as Chief Commercial Officer, worth about $191K. The recent filings there lean toward selling, a net 42,754 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2023 | BDSX Biodesix Inc | Chief Commercial Officer | Sale+OE | 1,699 | $1.33 | $2,255.65 | -1.8% | +2.3% | +22.3% | |
| May 10, 2023 | BDSX Biodesix Inc | Chief Commercial Officer | Sale+OE | 1,697 | $1.57 | $2,662.78 | -2.2% | -2.4% | -5.5% | |
| Feb 9, 2023 | BDSX Biodesix Inc | Chief Commercial Officer | Sale+OE | 1,999 | $1.80 | $3,596.40 | -8.0% | -6.3% | +5.7% | |
| Nov 10, 2022 | BDSX Biodesix Inc | Chief Commercial Officer | Sale+OE | 1,705 | $1.03 | $1,757.97 | -5.2% | +88.2% | +17.6% | |
| Aug 9, 2022 | BDSX Biodesix Inc | Chief Commercial Officer | Sale+OE | 1,673 | $2.53 | $4,229.68 | -12.8% | -55.6% | -44.0% | |
| May 10, 2022 | BDSX Biodesix Inc | Chief Commercial Officer | Sale+OE | 1,583 | $1.83 | $2,896.89 | -17.2% | +56.3% | -8.1% |